Subscribe To
Kuros Biosciences Reports Results for First Half 2023
(“Kuros” or the “Company”), a leader in next generation bone graft technologies, today reported a 148% growth in MagnetOs direct sales in the first six months of 2023. The enrollment of patients in … Read Full Story at source (may require registration) The post Kuros Biosciences Reports Results for First Half 2023 appeared first on ForexTV...
Read More
Posted: Aug 9 2023, 15:30
Author Name: forextv
Views: 022226